Patient preferences in Italy: health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetes

OBJECTIVES: Several glucagon-like peptide-1 receptor agonists are administered as weekly injections for treatment of type 2 diabetes (T2D). These medications vary in their injection processes, and a recent study in the UK found that these differences had an impact on patient preference and health st...

Descripción completa

Detalles Bibliográficos
Autores principales: Matza, Louis S, Boye, Kristina S, Jordan, Jessica B, Norrbacka, Kirsi, Gentilella, Raffaella, Tiebout, Amara R, Browne, Chantelle, Orsini Federici, Marco, Biricolti, Giovanni, Stewart, Katie D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995299/
https://www.ncbi.nlm.nih.gov/pubmed/29922043
http://dx.doi.org/10.2147/PPA.S159620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995299/
https://www.ncbi.nlm.nih.gov/pubmed/29922043
http://dx.doi.org/10.2147/PPA.S159620

Ejemplares similares